Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Case Western Reserve University, Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Case Western Reserve University, Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
UT Southwestern Medical Center
mi
from
Dallas, TX
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
University of Utah
mi
from
Salt Lake City, UT
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
Banner Health- Laboratory Sciences of Arizona
mi
from
Gilbert, AZ
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
Banner Health- Laboratory Sciences of Arizona
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
Accelerate Diagnostics Inc.
mi
from
Tucson, AZ
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
Accelerate Diagnostics Inc.
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
MRI Global
mi
from
Palm Bay, FL
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
MRI Global
mi
from
Palm Bay, FL
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
Loyola University Medical Center
mi
from
Maywood, IL
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
The Mayo Clinic
mi
from
Rochester, MN
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
Lab Alliance of Central New York LLC
mi
from
Liverpool, NY
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
Lab Alliance of Central New York LLC
mi
from
Liverpool, NY
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
Ohio State University
mi
from
Columbus, OH
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
Geisinger Clinic
mi
from
Danville, PA
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
Geisinger Clinic
mi
from
Danville, PA
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
med fusion LLC
mi
from
Lewisville, TX
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
med fusion LLC
mi
from
Lewisville, TX
Click here to add this to my saved trials
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated:  9/25/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing
Status: Enrolling
Updated: 9/25/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector
Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector
Status: Enrolling
Updated:  9/26/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector
Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector
Status: Enrolling
Updated: 9/26/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Rush University Medical Center
mi
from
Chicago, IL
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Johns Hopkins University
mi
from
Baltimore, MD
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Ohio State University
mi
from
Columbus, OH
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Oregon Health and Science University
mi
from
Portland, OR
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Avera Hematology & Transplant Center
mi
from
Sioux Falls, SD
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Avera Hematology & Transplant Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Texas Transplant Institute
mi
from
San Antonio, TX
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Texas Transplant Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
City of Hope National Medical Center
mi
from
Duarte, CA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of California, San Diego Medical Center
mi
from
La Jolla, CA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of California, San Diego Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Stanford Hospital and Clinics
mi
from
Stanford, CA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Colorado Blood Cancer Institute
mi
from
Denver, CO
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Colorado Blood Cancer Institute
mi
from
Denver, CO
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Florida College of Medicine
mi
from
Gainesville, FL
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
BMT Program at Northside Hospital
mi
from
Atlanta, GA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
BMT Program at Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Ann & Robert Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Ann & Robert Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Indiana BMT at Beech Grove
mi
from
Beech Grove, IN
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Indiana BMT at Beech Grove
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Maryland Medical Systems
mi
from
Baltimore, MD
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Maryland Medical Systems
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Tufts Medical Center
mi
from
Boston, MA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
DFCI, Massachusetts General Hospital
mi
from
Boston, MA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
DFCI, Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Dana-Farber Cancer Institute/Brigham & Women's Hospital
mi
from
Boston, MA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Dana-Farber Cancer Institute/Brigham & Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
The Mayo Clinic
mi
from
Rochester, MN
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Hackensack University Medical Center
mi
from
Hackensack, NJ
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Weill Cornell Medical College NY Presbyterian Hospital
mi
from
New York, NY
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Weill Cornell Medical College NY Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Pennsylvania Cancer Center
mi
from
Philadelphia, PA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Pennsylvania Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials